Literature DB >> 34774134

By any means necessary: why lowering insulin prices is relevant to racial health equity.

Monica E Peek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34774134      PMCID： PMC9172261          DOI： 10.1016/S0140-6736(21)02315-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   202.731


× No keyword cloud information.
  9 in total

Review 1.  Race, socioeconomic status, and health. The added effects of racism and discrimination.

Authors:  D R Williams
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Unveiling the Black Panther Party Legacy to Public Health.

Authors:  Alfredo Morabia
Journal:  Am J Public Health       Date:  2016-10       Impact factor: 9.308

Review 3.  Insulin Access and Affordability Working Group: Conclusions and Recommendations.

Authors:  William T Cefalu; Daniel E Dawes; Gina Gavlak; Dana Goldman; William H Herman; Karen Van Nuys; Alvin C Powers; Simeon I Taylor; Alan L Yatvin
Journal:  Diabetes Care       Date:  2018-05-08       Impact factor: 19.112

4.  The U.S. Insulin Crisis - Rationing a Lifesaving Medication Discovered in the 1920s.

Authors:  Michael Fralick; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2019-11-07       Impact factor: 91.245

Review 5.  Medication Adherence With Diabetes Medication: A Systematic Review of the Literature.

Authors:  Kam Capoccia; Peggy S Odegard; Nancy Letassy
Journal:  Diabetes Educ       Date:  2015-12-04       Impact factor: 2.140

6.  Clinical outcomes and incremental costs from a medication adherence pilot intervention targeting low-income patients with diabetes at risk of cost-related medication nonadherence.

Authors:  John G Ryan; Mark Fedders; Terri Jennings; Isabel Vittoria; Melissa Yanes
Journal:  Clin Ther       Date:  2014-10-02       Impact factor: 3.393

7.  Race/ethnic difference in diabetes and diabetic complications.

Authors:  Elias K Spanakis; Sherita Hill Golden
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

8.  Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.

Authors:  Xinyang Hua; Natalie Carvalho; Michelle Tew; Elbert S Huang; William H Herman; Philip Clarke
Journal:  JAMA       Date:  2016-04-05       Impact factor: 56.272

9.  Trends in Insulin Use and Diabetes Control in the U.S.: 1988-1994 and 1999-2012.

Authors:  Elizabeth Selvin; Christina M Parrinello; Natalie Daya; Richard M Bergenstal
Journal:  Diabetes Care       Date:  2015-12-30       Impact factor: 19.112
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.